Share Price and Basic Stock Data
Last Updated: December 13, 2025, 12:38 am
| PEG Ratio | 1.28 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Chembond Chemicals Ltd operates in the specialty chemicals sector, a space that has garnered increasing attention due to its growth potential. The company reported a revenue of ₹440 Cr for the fiscal year ending March 2023, marking a significant rise from ₹349 Cr in the previous year. However, the latest trailing twelve months (TTM) figure shows a decline to ₹286 Cr, raising questions about recent sales momentum. The quarterly sales figures indicate fluctuations, with the most recent quarter (June 2025) recording ₹57.68 Cr, which is a drop from ₹113.54 Cr in June 2023. This inconsistent revenue stream could reflect broader market challenges or operational inefficiencies that the company is facing, particularly as it tries to maintain its competitive edge in a rapidly changing industry landscape.
Profitability and Efficiency Metrics
When examining profitability, Chembond’s operating profit margin (OPM) has been on a rollercoaster ride, peaking at 12.95% in September 2023 before tapering to 6.02% by June 2025. This decline raises concerns about cost management and pricing strategies in a competitive environment. The net profit for the fiscal year ending March 2025 stood at ₹18 Cr, a drop from ₹25 Cr in the previous year, highlighting the pressures on profitability. Moreover, the return on equity (ROE) of 10.5% and return on capital employed (ROCE) of 11.5% reveal a moderate ability to generate returns from shareholders’ investments and employed capital. While these figures are decent, they may not stand out in comparison to industry benchmarks, indicating that Chembond needs to enhance its operational efficiency to improve shareholder value.
Balance Sheet Strength and Financial Ratios
Chembond’s balance sheet appears robust, with total borrowings reported at a mere ₹6 Cr against reserves of ₹155 Cr, showcasing a comfortable debt-to-equity ratio. This low level of debt allows for greater financial flexibility, especially in times of market volatility. The interest coverage ratio (ICR) of 71.55x is exceptionally strong, suggesting that the company can easily meet its interest obligations. However, the current ratio of 4.81 indicates a potential over-reliance on current assets, which could pose liquidity risks if not managed effectively. Moreover, the company’s cash conversion cycle has improved to 15 days, reflecting better efficiency in managing receivables and inventory, but investors should be cautious as any strain on cash flow could quickly alter this favorable position.
Shareholding Pattern and Investor Confidence
Investor confidence in Chembond Chemicals appears stable, with promoters holding 67.65% of the shares, indicating a strong commitment to the company’s future. However, foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold a marginal stake of 0.61% and 0.74%, respectively. This low institutional interest could be a double-edged sword; while it suggests that institutional investors may not fully endorse the company’s growth prospects, it also leaves room for retail investors to enter the fray. The number of shareholders has risen to 13,168, reflecting a growing interest among retail investors. This trend could be a positive sign, but the lack of institutional backing warrants careful scrutiny of the company’s operational and strategic direction.
Outlook, Risks, and Final Insight
Looking ahead, Chembond Chemicals faces a mixed bag of opportunities and challenges. The fluctuations in revenue and profitability metrics suggest that the company must address operational inefficiencies to regain momentum. Additionally, the low institutional investment raises a flag regarding broader market confidence in its growth strategy. While the strong balance sheet and promoter backing provide a solid foundation, investors should be cautious of market volatility and sector-specific risks that could impact performance. With the specialty chemicals market evolving, Chembond will need to innovate and adapt to maintain its position. Investors might consider keeping a close eye on quarterly performance trends and any strategic initiatives aimed at bolstering sales and profitability, while also assessing the overall economic climate that could influence demand for specialty chemicals.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 394 Cr. | 42.9 | 83.5/41.2 | 24.5 | 20.5 | 0.93 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 31.9 Cr. | 64.9 | 99.5/56.0 | 15.2 | 89.6 | 1.54 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 45.6 Cr. | 670 | 960/600 | 21.0 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,470 Cr. | 76.5 | 111/74.5 | 23.0 | 22.0 | 0.65 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 651 Cr. | 261 | 453/241 | 23.4 | 93.8 | 0.96 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,832.80 Cr | 725.78 | 65.85 | 183.02 | 0.44% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 97.65 | 110.14 | 110.62 | 122.03 | 113.54 | 112.02 | 114.60 | 47.09 | 46.27 | 123.53 | 53.05 | 52.21 | 57.68 |
| Expenses | 96.66 | 100.93 | 99.46 | 108.81 | 104.59 | 97.51 | 100.44 | 44.01 | 42.83 | 110.87 | 49.27 | 48.61 | 54.21 |
| Operating Profit | 0.99 | 9.21 | 11.16 | 13.22 | 8.95 | 14.51 | 14.16 | 3.08 | 3.44 | 12.66 | 3.78 | 3.60 | 3.47 |
| OPM % | 1.01% | 8.36% | 10.09% | 10.83% | 7.88% | 12.95% | 12.36% | 6.54% | 7.43% | 10.25% | 7.13% | 6.90% | 6.02% |
| Other Income | 0.40 | 1.10 | 1.46 | 1.67 | 3.01 | 9.31 | 3.59 | 0.89 | 2.09 | 6.93 | 0.19 | 1.72 | 2.65 |
| Interest | 0.14 | 0.19 | 0.21 | 0.50 | 0.26 | 0.46 | 0.32 | 0.20 | 0.16 | 0.31 | 0.18 | 0.14 | 0.07 |
| Depreciation | 1.05 | 1.08 | 1.07 | 1.31 | 1.06 | 1.47 | 1.38 | 0.88 | 0.57 | 1.86 | 0.68 | 0.70 | 0.68 |
| Profit before tax | 0.20 | 9.04 | 11.34 | 13.08 | 10.64 | 21.89 | 16.05 | 2.89 | 4.80 | 17.42 | 3.11 | 4.48 | 5.37 |
| Tax % | 770.00% | 14.05% | 26.72% | 22.48% | 17.39% | 29.79% | 16.01% | 47.75% | 2.29% | 20.49% | -4.18% | 25.22% | 25.70% |
| Net Profit | -1.34 | 7.77 | 8.25 | 10.19 | 8.78 | 15.35 | 13.49 | 1.51 | 4.68 | 13.85 | 3.24 | 3.36 | 3.99 |
| EPS in Rs | -1.02 | 5.77 | 6.16 | 7.61 | 6.54 | 11.52 | 10.07 | 1.13 | 3.49 | 10.35 | 2.42 | 2.51 | 2.98 |
Last Updated: August 1, 2025, 10:45 pm
Below is a detailed analysis of the quarterly data for Chembond Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 57.68 Cr.. The value appears strong and on an upward trend. It has increased from 52.21 Cr. (Mar 2025) to 57.68 Cr., marking an increase of 5.47 Cr..
- For Expenses, as of Jun 2025, the value is 54.21 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 48.61 Cr. (Mar 2025) to 54.21 Cr., marking an increase of 5.60 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.47 Cr.. The value appears to be declining and may need further review. It has decreased from 3.60 Cr. (Mar 2025) to 3.47 Cr., marking a decrease of 0.13 Cr..
- For OPM %, as of Jun 2025, the value is 6.02%. The value appears to be declining and may need further review. It has decreased from 6.90% (Mar 2025) to 6.02%, marking a decrease of 0.88%.
- For Other Income, as of Jun 2025, the value is 2.65 Cr.. The value appears strong and on an upward trend. It has increased from 1.72 Cr. (Mar 2025) to 2.65 Cr., marking an increase of 0.93 Cr..
- For Interest, as of Jun 2025, the value is 0.07 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.14 Cr. (Mar 2025) to 0.07 Cr., marking a decrease of 0.07 Cr..
- For Depreciation, as of Jun 2025, the value is 0.68 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.70 Cr. (Mar 2025) to 0.68 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is 5.37 Cr.. The value appears strong and on an upward trend. It has increased from 4.48 Cr. (Mar 2025) to 5.37 Cr., marking an increase of 0.89 Cr..
- For Tax %, as of Jun 2025, the value is 25.70%. The value appears to be increasing, which may not be favorable. It has increased from 25.22% (Mar 2025) to 25.70%, marking an increase of 0.48%.
- For Net Profit, as of Jun 2025, the value is 3.99 Cr.. The value appears strong and on an upward trend. It has increased from 3.36 Cr. (Mar 2025) to 3.99 Cr., marking an increase of 0.63 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.98. The value appears strong and on an upward trend. It has increased from 2.51 (Mar 2025) to 2.98, marking an increase of 0.47.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:31 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 274 | 299 | 270 | 291 | 327 | 301 | 268 | 274 | 349 | 440 | 178 | 201 | 286 |
| Expenses | 253 | 273 | 259 | 274 | 304 | 275 | 258 | 256 | 332 | 405 | 172 | 188 | 263 |
| Operating Profit | 21 | 26 | 11 | 17 | 23 | 26 | 10 | 18 | 17 | 35 | 7 | 14 | 24 |
| OPM % | 8% | 9% | 4% | 6% | 7% | 8% | 4% | 7% | 5% | 8% | 4% | 7% | 8% |
| Other Income | 1 | 1 | 189 | 18 | 11 | 4 | 3 | 15 | 9 | 5 | 14 | 9 | 11 |
| Interest | 4 | 4 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 3 | 3 | 4 |
| Profit before tax | 15 | 20 | 195 | 30 | 28 | 24 | 8 | 29 | 21 | 34 | 17 | 19 | 30 |
| Tax % | 40% | 28% | 20% | 24% | 16% | 19% | 61% | 28% | 32% | 26% | 33% | 10% | |
| Net Profit | 9 | 14 | 156 | 23 | 24 | 20 | 3 | 20 | 14 | 25 | 11 | 18 | 24 |
| EPS in Rs | 5.76 | 9.24 | 114.66 | 14.43 | 16.40 | 12.93 | 1.40 | 15.18 | 10.39 | 18.73 | 8.34 | 13.10 | 18.26 |
| Dividend Payout % | 26% | 16% | 4% | 11% | 11% | 16% | 144% | 15% | 48% | 16% | 42% | 13% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 55.56% | 1014.29% | -85.26% | 4.35% | -16.67% | -85.00% | 566.67% | -30.00% | 78.57% | -56.00% | 63.64% |
| Change in YoY Net Profit Growth (%) | 0.00% | 958.73% | -1099.54% | 89.60% | -21.01% | -68.33% | 651.67% | -596.67% | 108.57% | -134.57% | 119.64% |
Chembond Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -6% |
| 3 Years: | -17% |
| TTM: | -10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 54% |
| 3 Years: | 4% |
| TTM: | -34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 8% |
| 3 Years: | 7% |
| 1 Year: | -62% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 6% |
| 3 Years: | 7% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 1:50 am
Balance Sheet
Last Updated: December 4, 2025, 1:06 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 80 | 89 | 200 | 223 | 242 | 255 | 262 | 286 | 297 | 315 | 137 | 149 | 155 |
| Borrowings | 33 | 25 | 11 | 9 | 9 | 7 | 3 | 2 | 2 | 7 | 7 | 3 | 6 |
| Other Liabilities | 86 | 83 | 72 | 82 | 68 | 54 | 50 | 59 | 56 | 74 | 41 | 43 | 44 |
| Total Liabilities | 205 | 203 | 289 | 321 | 325 | 322 | 322 | 354 | 361 | 402 | 191 | 202 | 211 |
| Fixed Assets | 54 | 51 | 47 | 49 | 108 | 109 | 124 | 122 | 121 | 116 | 26 | 34 | 41 |
| CWIP | 3 | 3 | 2 | 2 | 1 | 2 | 0 | 0 | 1 | 12 | 13 | 8 | 1 |
| Investments | 1 | 1 | 88 | 150 | 76 | 58 | 51 | 73 | 75 | 65 | 65 | 78 | 68 |
| Other Assets | 148 | 147 | 152 | 120 | 140 | 153 | 147 | 160 | 165 | 208 | 87 | 83 | 101 |
| Total Assets | 205 | 203 | 289 | 321 | 325 | 322 | 322 | 354 | 361 | 402 | 191 | 202 | 211 |
Below is a detailed analysis of the balance sheet data for Chembond Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
- For Reserves, as of Sep 2025, the value is 155.00 Cr.. The value appears strong and on an upward trend. It has increased from 149.00 Cr. (Mar 2025) to 155.00 Cr., marking an increase of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 44.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 43.00 Cr. (Mar 2025) to 44.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 211.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 202.00 Cr. (Mar 2025) to 211.00 Cr., marking an increase of 9.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 41.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2025) to 41.00 Cr., marking an increase of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 7.00 Cr..
- For Investments, as of Sep 2025, the value is 68.00 Cr.. The value appears to be declining and may need further review. It has decreased from 78.00 Cr. (Mar 2025) to 68.00 Cr., marking a decrease of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 101.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Mar 2025) to 101.00 Cr., marking an increase of 18.00 Cr..
- For Total Assets, as of Sep 2025, the value is 211.00 Cr.. The value appears strong and on an upward trend. It has increased from 202.00 Cr. (Mar 2025) to 211.00 Cr., marking an increase of 9.00 Cr..
Notably, the Reserves (155.00 Cr.) exceed the Borrowings (6.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -12.00 | 1.00 | 0.00 | 8.00 | 14.00 | 19.00 | 7.00 | 16.00 | 15.00 | 28.00 | 0.00 | 11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 116 | 105 | 78 | 84 | 90 | 110 | 112 | 111 | 94 | 96 | 100 | 72 |
| Inventory Days | 74 | 60 | 46 | 59 | 46 | 58 | 77 | 82 | 67 | 53 | 58 | 56 |
| Days Payable | 113 | 96 | 86 | 95 | 96 | 84 | 96 | 120 | 76 | 81 | 118 | 113 |
| Cash Conversion Cycle | 77 | 70 | 38 | 49 | 40 | 84 | 94 | 73 | 84 | 67 | 40 | 15 |
| Working Capital Days | 53 | 45 | 90 | 42 | 44 | 82 | 98 | 83 | 78 | 70 | 39 | 25 |
| ROCE % | 15% | 18% | 22% | 12% | 11% | 9% | 3% | 10% | 7% | 10% | 5% | 12% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 |
|---|---|---|
| FaceValue | 5.00 | 5.00 |
| Basic EPS (Rs.) | 11.54 | 11.20 |
| Diluted EPS (Rs.) | 11.54 | 11.20 |
| Cash EPS (Rs.) | 13.33 | 12.13 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 64.77 | 53.13 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 64.77 | 53.13 |
| Revenue From Operations / Share (Rs.) | 108.67 | 105.31 |
| PBDIT / Share (Rs.) | 17.76 | 16.97 |
| PBIT / Share (Rs.) | 15.93 | 16.00 |
| PBT / Share (Rs.) | 15.68 | 15.78 |
| Net Profit / Share (Rs.) | 11.49 | 11.16 |
| NP After MI And SOA / Share (Rs.) | 11.54 | 11.20 |
| PBDIT Margin (%) | 16.34 | 16.11 |
| PBIT Margin (%) | 14.65 | 15.19 |
| PBT Margin (%) | 14.42 | 14.98 |
| Net Profit Margin (%) | 10.57 | 10.59 |
| NP After MI And SOA Margin (%) | 10.62 | 10.63 |
| Return on Networth / Equity (%) | 17.81 | 21.07 |
| Return on Capital Employeed (%) | 24.05 | 29.22 |
| Return On Assets (%) | 14.36 | 16.50 |
| Asset Turnover Ratio (%) | 1.47 | 0.00 |
| Current Ratio (X) | 4.81 | 4.32 |
| Quick Ratio (X) | 4.33 | 3.83 |
| Inventory Turnover Ratio (X) | 16.42 | 0.00 |
| Interest Coverage Ratio (X) | 71.55 | 76.92 |
| Interest Coverage Ratio (Post Tax) (X) | 47.31 | 51.58 |
After reviewing the key financial ratios for Chembond Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 11.54, marking an increase of 0.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 11.54, marking an increase of 0.34.
- For Cash EPS (Rs.), as of Mar 25, the value is 13.33. This value is within the healthy range. It has increased from 12.13 (Mar 24) to 13.33, marking an increase of 1.20.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 64.77. It has increased from 53.13 (Mar 24) to 64.77, marking an increase of 11.64.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 64.77. It has increased from 53.13 (Mar 24) to 64.77, marking an increase of 11.64.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 108.67. It has increased from 105.31 (Mar 24) to 108.67, marking an increase of 3.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 17.76. This value is within the healthy range. It has increased from 16.97 (Mar 24) to 17.76, marking an increase of 0.79.
- For PBIT / Share (Rs.), as of Mar 25, the value is 15.93. This value is within the healthy range. It has decreased from 16.00 (Mar 24) to 15.93, marking a decrease of 0.07.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.68. This value is within the healthy range. It has decreased from 15.78 (Mar 24) to 15.68, marking a decrease of 0.10.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.49. This value is within the healthy range. It has increased from 11.16 (Mar 24) to 11.49, marking an increase of 0.33.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 11.54, marking an increase of 0.34.
- For PBDIT Margin (%), as of Mar 25, the value is 16.34. This value is within the healthy range. It has increased from 16.11 (Mar 24) to 16.34, marking an increase of 0.23.
- For PBIT Margin (%), as of Mar 25, the value is 14.65. This value is within the healthy range. It has decreased from 15.19 (Mar 24) to 14.65, marking a decrease of 0.54.
- For PBT Margin (%), as of Mar 25, the value is 14.42. This value is within the healthy range. It has decreased from 14.98 (Mar 24) to 14.42, marking a decrease of 0.56.
- For Net Profit Margin (%), as of Mar 25, the value is 10.57. This value exceeds the healthy maximum of 10. It has decreased from 10.59 (Mar 24) to 10.57, marking a decrease of 0.02.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.62. This value is within the healthy range. It has decreased from 10.63 (Mar 24) to 10.62, marking a decrease of 0.01.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.81. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 17.81, marking a decrease of 3.26.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.05. This value is within the healthy range. It has decreased from 29.22 (Mar 24) to 24.05, marking a decrease of 5.17.
- For Return On Assets (%), as of Mar 25, the value is 14.36. This value is within the healthy range. It has decreased from 16.50 (Mar 24) to 14.36, marking a decrease of 2.14.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.47. It has increased from 0.00 (Mar 24) to 1.47, marking an increase of 1.47.
- For Current Ratio (X), as of Mar 25, the value is 4.81. This value exceeds the healthy maximum of 3. It has increased from 4.32 (Mar 24) to 4.81, marking an increase of 0.49.
- For Quick Ratio (X), as of Mar 25, the value is 4.33. This value exceeds the healthy maximum of 2. It has increased from 3.83 (Mar 24) to 4.33, marking an increase of 0.50.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 16.42. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 16.42, marking an increase of 16.42.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 71.55. This value is within the healthy range. It has decreased from 76.92 (Mar 24) to 71.55, marking a decrease of 5.37.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 47.31. This value is within the healthy range. It has decreased from 51.58 (Mar 24) to 47.31, marking a decrease of 4.27.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Chembond Chemicals Ltd:
- Net Profit Margin: 10.57%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.05% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.81% (Industry Average ROE: 24.61%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 47.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 15.3 (Industry average Stock P/E: 57.62)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.57%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Chembond Centre, EL71, MIDC Mahape, New Mumbai Maharashtra 400710 | info@chembond.in http://www.chembond.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sameer V Shah | Chairman & Managing Director |
| Mr. Nirmal V Shah | Non Executive Director |
| Mr. Jayesh P Shah | Independent Director |
| Mrs. Gorsi A Parekh | Independent Director |
| Mr. Jaywant K Tawade | Additional Executive Director |
| Mr. Kamal Tandon | Addnl.Independent Director |
| Mr. Mayank P Shah | Independent Director |
FAQ
What is the intrinsic value of Chembond Chemicals Ltd?
Chembond Chemicals Ltd's intrinsic value (as of 13 December 2025) is 157.16 which is 4.17% lower the current market price of 164.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 221 Cr. market cap, FY2025-2026 high/low of 490/152, reserves of ₹155 Cr, and liabilities of 211 Cr.
What is the Market Cap of Chembond Chemicals Ltd?
The Market Cap of Chembond Chemicals Ltd is 221 Cr..
What is the current Stock Price of Chembond Chemicals Ltd as on 13 December 2025?
The current stock price of Chembond Chemicals Ltd as on 13 December 2025 is 164.
What is the High / Low of Chembond Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Chembond Chemicals Ltd stocks is 490/152.
What is the Stock P/E of Chembond Chemicals Ltd?
The Stock P/E of Chembond Chemicals Ltd is 15.3.
What is the Book Value of Chembond Chemicals Ltd?
The Book Value of Chembond Chemicals Ltd is 121.
What is the Dividend Yield of Chembond Chemicals Ltd?
The Dividend Yield of Chembond Chemicals Ltd is 1.06 %.
What is the ROCE of Chembond Chemicals Ltd?
The ROCE of Chembond Chemicals Ltd is 11.5 %.
What is the ROE of Chembond Chemicals Ltd?
The ROE of Chembond Chemicals Ltd is 10.5 %.
What is the Face Value of Chembond Chemicals Ltd?
The Face Value of Chembond Chemicals Ltd is 5.00.